Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $14.59 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-26.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2021-03-26
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2020 was $14.59K, a 1057.70% increase from fiscal 2019.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2019 was $1.26K.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2018 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2016 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|
| 2020-12-31 | $14.59K 10-K · filed 2021-03-26 |
| 2019-12-31 | $1.26K 10-K · filed 2020-03-30 |
| 2018-12-31 | $0.00 10-K · filed 2019-03-07 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-16 |